Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto (ICBAS-UP), Porto 4050-313, Portugal.
CINTESIS@RISE, Center for Health Technology and Services Research at The Associate Laboratory RISE-Health Research Network, Faculty of Medicine of The University of Porto, Porto 4200-219, Portugal.
World J Gastroenterol. 2023 Feb 14;29(6):1109-1122. doi: 10.3748/wjg.v29.i6.1109.
The impact caused by the coronavirus disease 2019 (COVID-19) on the Portuguese population has been addressed in areas such as clinical manifestations, frequent comorbidities, and alterations in consumption habits. However, comorbidities like liver conditions and changes concerning the Portuguese population's access to healthcare-related services have received less attention.
To (1) Review the impact of COVID-19 on the healthcare system; (2) examine the relationship between liver diseases and COVID-19 in infected individuals; and (3) investigate the situation in the Portuguese population concerning these topics.
For our purposes, we conducted a literature review using specific keywords.
COVID-19 is frequently associated with liver damage. However, liver injury in COVID-19 individuals is a multifactor-mediated effect. Therefore, it remains unclear whether changes in liver laboratory tests are associated with a worse prognosis in Portuguese individuals with COVID-19.
COVID-19 has impacted healthcare systems in Portugal and other countries; the combination of COVID-19 with liver injury is common. Previous liver damage may represent a risk factor that worsens the prognosis in individuals with COVID-19.
新型冠状病毒病 2019（COVID-19）对葡萄牙人口的影响已在临床表现、常见合并症和消费习惯改变等方面得到解决。然而，像肝脏疾病等合并症以及葡萄牙人口获得与医疗保健相关的服务的变化等问题受到的关注较少。
（1）综述 COVID-19 对医疗保健系统的影响；（2）研究感染个体中肝脏疾病与 COVID-19 之间的关系；（3）调查葡萄牙人群在这些问题上的情况。
为此，我们使用特定关键词进行了文献回顾。
COVID-19 常与肝损伤相关。然而，COVID-19 个体中的肝损伤是多因素介导的效应。因此，尚不清楚 COVID-19 葡萄牙个体的肝脏实验室检查结果变化是否与预后较差相关。
COVID-19 已对葡萄牙和其他国家的医疗保健系统产生影响；COVID-19 合并肝损伤很常见。先前的肝损伤可能代表 COVID-19 个体预后恶化的危险因素。
